NAV NAVCO Pharmaceuticals Inc

Goldman Sachs U.S. Income Builder Trust (the "Fund") (TSX:GSB.UN) is pleased to
announce that as of July 4, 2014, the Fund has invested approximately 90% of the
net proceeds it received from its initial public offering plus leverage. The
investment objectives of the Fund are to seek to provide (i) income; and (ii)
capital appreciation, in each case, through investing in an actively managed,
diversified portfolio comprised primarily of U.S. fixed income and equity
securities. Goldman Sachs Asset Management, L.P. ("GSAM") has been retained as
the sub-adviser of the Fund and draws on its deep research capabilities and
global team of investment professionals from its Global Fixed Income and
Fundamental Equity Groups to select investments for the portfolio. 


The Fund is also pleased to announce its first distribution in the amount of
$0.05278 per Class A unit to be paid on August 15, 2014 to unitholders of record
at the close of business on July 31, 2014. This distribution covers the period
from the closing of the initial public offering on June 23, 2014 to July 31,
2014 and is, therefore, higher than the anticipated normal monthly distribution
rate.


The Fund also announces distributions in the amount of $0.04167 per Class A unit
for record dates in August and September 2014 as follows:




Record Date                 Payment Date             
August 29, 2014             September 15, 2014       
September 30, 2014          October 15, 2014         



Goldman Sachs U.S. Income Builder Trust also announces a distribution in the
amount of US$0.05278 per Class U unit payable on August 15, 2014 to unitholders
of record on July 31, 2014, as well as a distribution in the amount of
US$0.04167 per Class U unit for record dates in August and September as noted
above.


The Fund is pleased to announce that it has initiated a distribution
reinvestment plan ("DRIP") that is available for both the Class A units and the
Class U units beginning with the July 31, 2014 record date. The DRIP provides
unitholders with the ability to automatically reinvest distributions and realize
the benefits of compound growth. Under the DRIP, for the Class A units, if the
10 day weighted average trading price prior to the distribution payment date
(the "Trading Price") is higher than the net asset value per unit ("NAV"), such
that the Fund is trading at a premium to NAV, Class A unitholders will benefit
from reinvesting distributions at a lower value, generally being NAV. If the
Trading Price of the Class A units is lower than the NAV, such that the Fund is
trading at a discount to NAV, Class A unitholders will generally benefit from
reinvesting at below NAV through the acquisition of units in the market. Class U
units will be issued by the Fund at a price equal to the Net Asset Value per
Unit of the Class U units. The DRIP provides an attractive reinvestment
mechanism in both circumstances when the Fund trades at a premium or a discount
to NAV. Contact your investment advisor to enroll in the Fund's DRIP and please
visit our website for complete details of the DRIP plan.


About Brompton Funds

Brompton Funds, a division of Brompton Group, is an experienced investment fund
manager operating since 2002. Brompton is focused on meeting the needs of
investors by offering low cost, innovative products with client friendly terms
and supported by strong corporate governance. For further information, please
contact your investment advisor, call Brompton's investor relations line at
416-642-9051, (toll-free at 1-866-642-6001) email info@bromptongroup.com or
visit our website at www.bromptongroup.com. 


About Goldman Sachs Asset Management 

GSAM is the asset management arm of The Goldman Sachs Group, Inc. (NYSE:GS),
which manages $956 billion as of March 31, 2014. GSAM has been providing
discretionary investment advisory services since 1988 and has investment
professionals in all major financial centers around the world. The company
offers investment strategies across a broad range of asset classes to
institutional and individual clients globally. Founded in 1869, Goldman Sachs is
a leading global investment banking, securities and investment management firm
that provides a wide range of financial services to a substantial and
diversified client base that includes corporations, financial institutions,
governments and high-net-worth individuals.


Commissions, trailing commissions, management fees and expenses all may be
associated with investment funds. Please read the Fund's publicly filed
documents which are available from SEDAR at www.sedar.com. Investment funds are
not guaranteed, their values change frequently and past performance may not be
repeated.


Certain statements contained in this news release constitute forward-looking
information within the meaning of Canadian securities laws. Forward-looking
information may relate to matters disclosed in this press release and to other
matters identified in public filings relating to the Fund, to the future outlook
of the Fund and anticipated events or results and may include statements
regarding the future financial performance of the Fund. In some cases,
forward-looking information can be identified by terms such as "may", "will",
"should", "expect", "plan", "anticipate", "believe", "intend", "estimate",
"predict", "potential", "continue" or other similar expressions concerning
matters that are not historical facts. Actual results may vary from such
forward-looking information. Investors should not place undue reliance on
forward-looking statements. These forward-looking statements are made as of the
date hereof and we assume no obligation to update or revise them to reflect new
events or circumstances.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Brompton's investor relations line
416-642-9051 (toll-free at 1-866-642-6001)
info@bromptongroup.com
www.bromptongroup.com

NAVCO Pharmaceuticals (TSXV:NAV)
Historical Stock Chart
From Nov 2024 to Dec 2024

NAVCO Pharmaceuticals (TSXV:NAV)
Historical Stock Chart
From Dec 2023 to Dec 2024